Inspyr Therapeutics Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 241K |
---|---|---|---|---|---|
Net income 2021 | 2M | Net income 2022 | -1M | EV / Sales 2021 | - |
Net cash position 2021 | 197K | Net Debt 2022 | 305K | EV / Sales 2022 | - |
P/E ratio 2021 |
-0.4
x | P/E ratio 2022 |
-0.23
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Michael Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 16-10-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 08-01-31 | |
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Claire Thomas
BRD | Director/Board Member | 68 | 16-10-11 |
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+4.15% | 97.47B | |
+5.85% | 22.25B | |
-13.46% | 21.68B | |
-9.37% | 18.2B | |
-39.98% | 17.02B | |
-11.31% | 16.36B | |
+7.13% | 14.39B | |
+40.66% | 12.37B |